WO2000061806A2 - GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS - Google Patents
GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS Download PDFInfo
- Publication number
- WO2000061806A2 WO2000061806A2 PCT/US2000/008611 US0008611W WO0061806A2 WO 2000061806 A2 WO2000061806 A2 WO 2000061806A2 US 0008611 W US0008611 W US 0008611W WO 0061806 A2 WO0061806 A2 WO 0061806A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- molecule
- capture
- nucleic acid
- group
- solid support
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00919976A EP1183387A2 (en) | 1999-04-09 | 2000-03-31 | GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
AU40581/00A AU4058100A (en) | 1999-04-09 | 2000-03-31 | Generic cdna or protein array for customized assays |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12857899P | 1999-04-09 | 1999-04-09 | |
US60/128,578 | 1999-04-09 | ||
US53886200A | 2000-03-29 | 2000-03-29 | |
US09/538,862 | 2000-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000061806A2 true WO2000061806A2 (en) | 2000-10-19 |
WO2000061806A3 WO2000061806A3 (en) | 2001-12-20 |
Family
ID=26826721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/008611 WO2000061806A2 (en) | 1999-04-09 | 2000-03-31 | GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1183387A2 (en) |
AU (1) | AU4058100A (en) |
WO (1) | WO2000061806A2 (en) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1275737A2 (en) * | 2001-06-30 | 2003-01-15 | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. | Compositions and processes for analyte detection; quantification and amplification |
WO2003006657A2 (en) * | 2001-07-13 | 2003-01-23 | Custos Biotechnologie Gmbh | Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours |
WO2003062462A2 (en) * | 2002-01-16 | 2003-07-31 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
DE112006003608T5 (en) | 2006-01-02 | 2008-10-30 | Korea Advanced Institute Of Science And Technology | A method of presenting target proteins at the cell surface using Bacillus Anthracis Exosporium |
WO2010107825A2 (en) | 2009-03-16 | 2010-09-23 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
WO2010120509A2 (en) | 2009-03-31 | 2010-10-21 | Atyr Pharma, Inc. | Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
WO2011135459A2 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
WO2011139986A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
WO2011139714A2 (en) | 2010-04-26 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
WO2011140135A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
WO2011140132A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
WO2011139799A2 (en) | 2010-04-27 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
WO2011140267A2 (en) | 2010-05-04 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
WO2011139907A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
WO2011139854A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
WO2011139853A2 (en) | 2010-04-28 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
WO2011143482A2 (en) | 2010-05-14 | 2011-11-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
WO2011146410A2 (en) | 2010-05-17 | 2011-11-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
WO2011150279A2 (en) | 2010-05-27 | 2011-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
WO2011153277A2 (en) | 2010-06-01 | 2011-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
WO2012021247A2 (en) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
WO2012027611A2 (en) | 2010-08-25 | 2012-03-01 | Atyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
US8158387B2 (en) | 2004-06-17 | 2012-04-17 | Korea Advanced Institute Of Science And Technology | Method for cell surface display of target proteins using FadL of E. coli |
WO2012163541A1 (en) | 2011-06-01 | 2012-12-06 | Medical Prognosis Institute A/S | Methods and devices for prognosis of cancer relapse |
US8431336B2 (en) | 2000-07-07 | 2013-04-30 | Diagnostics For The Real World, Ltd. | Binding interactions in dipstick assays |
WO2013123432A2 (en) | 2012-02-16 | 2013-08-22 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
WO2014085434A1 (en) | 2012-11-27 | 2014-06-05 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
WO2014195032A1 (en) | 2013-06-07 | 2014-12-11 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
US9068948B2 (en) | 2002-03-12 | 2015-06-30 | Enzo Life Sciences, Inc. | Processes for detection of nucleic acids |
WO2016008048A1 (en) | 2014-07-15 | 2016-01-21 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
US9777312B2 (en) | 2001-06-30 | 2017-10-03 | Enzo Life Sciences, Inc. | Dual polarity analysis of nucleic acids |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2235689A (en) * | 1989-09-06 | 1991-03-13 | Ici Plc | Amplification of a target nucleotide sequence |
WO1993025563A1 (en) * | 1992-06-17 | 1993-12-23 | City Of Hope | A method of detecting and discriminating between nucleic acid sequences |
EP0698792A1 (en) * | 1993-05-10 | 1996-02-28 | Nissui Pharmaceutical Co., Ltd. | Method for assaying more than one immunological ligand, and assay reagent and kit therefor |
WO1997031256A2 (en) * | 1996-02-09 | 1997-08-28 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
EP0846776A2 (en) * | 1996-12-06 | 1998-06-10 | Vysis, Inc. | Devices and methods for detecting multiple analytes in samples |
WO1998059243A1 (en) * | 1997-06-24 | 1998-12-30 | The Trustees Of Boston University | High density streptavidin supports |
WO1999015893A1 (en) * | 1997-09-22 | 1999-04-01 | Aventis Research & Technologies Gmbh & Co. Kg | Addressable modular recognition system, production mode and use |
WO1999032663A2 (en) * | 1997-12-19 | 1999-07-01 | Stephen Felder | High throughput assay system |
WO2000047767A1 (en) * | 1999-02-11 | 2000-08-17 | Astrazeneca Ab | Oligonucleotide array and methods of use |
WO2000058516A2 (en) * | 1999-03-26 | 2000-10-05 | Whitehead Institute For Biomedical Research | Universal arrays |
-
2000
- 2000-03-31 AU AU40581/00A patent/AU4058100A/en not_active Abandoned
- 2000-03-31 EP EP00919976A patent/EP1183387A2/en not_active Withdrawn
- 2000-03-31 WO PCT/US2000/008611 patent/WO2000061806A2/en not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2235689A (en) * | 1989-09-06 | 1991-03-13 | Ici Plc | Amplification of a target nucleotide sequence |
WO1993025563A1 (en) * | 1992-06-17 | 1993-12-23 | City Of Hope | A method of detecting and discriminating between nucleic acid sequences |
EP0698792A1 (en) * | 1993-05-10 | 1996-02-28 | Nissui Pharmaceutical Co., Ltd. | Method for assaying more than one immunological ligand, and assay reagent and kit therefor |
WO1997031256A2 (en) * | 1996-02-09 | 1997-08-28 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
EP0846776A2 (en) * | 1996-12-06 | 1998-06-10 | Vysis, Inc. | Devices and methods for detecting multiple analytes in samples |
WO1998059243A1 (en) * | 1997-06-24 | 1998-12-30 | The Trustees Of Boston University | High density streptavidin supports |
WO1999015893A1 (en) * | 1997-09-22 | 1999-04-01 | Aventis Research & Technologies Gmbh & Co. Kg | Addressable modular recognition system, production mode and use |
WO1999032663A2 (en) * | 1997-12-19 | 1999-07-01 | Stephen Felder | High throughput assay system |
WO2000047767A1 (en) * | 1999-02-11 | 2000-08-17 | Astrazeneca Ab | Oligonucleotide array and methods of use |
WO2000058516A2 (en) * | 1999-03-26 | 2000-10-05 | Whitehead Institute For Biomedical Research | Universal arrays |
Non-Patent Citations (1)
Title |
---|
NIEMEYER C M ET AL: "OLIGONUCLEOTIDE-DIRECTED SELF-ASSEMBLY OF PROTEINS: SEMISYNTHETIC DNA-STREPTAVIDIN HYBRID MOLECULES AS CONNECTORS FOR THE GENERATION OF MACROSCOPIC ARRAYS AND THE CONSTRUCTION OF SUPRAMOLECULAR BIOCONJUGATES" NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 22, no. 25, 1994, pages 5530-5539, XP000645135 ISSN: 0305-1048 * |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8431336B2 (en) | 2000-07-07 | 2013-04-30 | Diagnostics For The Real World, Ltd. | Binding interactions in dipstick assays |
US9771667B2 (en) | 2001-06-30 | 2017-09-26 | Enzo Life Sciences, Inc. | Arrays comprising chimeric compositions |
EP1275737A2 (en) * | 2001-06-30 | 2003-01-15 | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. | Compositions and processes for analyte detection; quantification and amplification |
US9617585B2 (en) | 2001-06-30 | 2017-04-11 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying more than one nucleic acid in a library |
US9309563B2 (en) | 2001-06-30 | 2016-04-12 | Enzo Life Sciences, Inc. | Compositions and processes for analyte detection, quantification and amplification |
US9279147B2 (en) | 2001-06-30 | 2016-03-08 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying analytes of interest |
US9777406B2 (en) | 2001-06-30 | 2017-10-03 | Enzo Biochem, Inc. | Process for detecting or quantifying nucleic acids in a library |
US9234234B2 (en) | 2001-06-30 | 2016-01-12 | Enzo Life Sciences, Inc. | Detection and quantification process for more than one nucleic acid in library |
EP2360274A1 (en) * | 2001-06-30 | 2011-08-24 | Enzo Life Sciences, Inc. | Compositions and processes for analyte detection; quantification and amplification |
EP2361992A1 (en) * | 2001-06-30 | 2011-08-31 | Enzo Life Sciences, Inc. | Compositions and processes for analyte detection; quantification and amplification |
US9163280B2 (en) | 2001-06-30 | 2015-10-20 | Enzo Life Sciences, Inc. | Process for detecting or quantifying nucleic acids in a library |
US9873956B2 (en) | 2001-06-30 | 2018-01-23 | Enzo Biochem, Inc. | Compositions and processes for analyte detection, quantification and amplification |
US9057100B2 (en) | 2001-06-30 | 2015-06-16 | Enzo Life Sciences, Inc. | Composition comprising array of nucleic acid primer sets |
US9434984B2 (en) | 2001-06-30 | 2016-09-06 | Enzo Life Sciences, Inc. | Composition comprising an array which further comprises chimeric compositions |
US9611508B2 (en) | 2001-06-30 | 2017-04-04 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying nucleic acids in a library |
US9487821B2 (en) | 2001-06-30 | 2016-11-08 | Enzo Life Sciences, Inc. | Composition comprising library of double stranded nucleic acids |
US9765387B2 (en) | 2001-06-30 | 2017-09-19 | Enzo Biochem, Inc. | Process for detecting or quantifying nucleic acids in a library |
US8597888B2 (en) | 2001-06-30 | 2013-12-03 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying more than one nucleic acid in a library |
US8557522B2 (en) | 2001-06-30 | 2013-10-15 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying more than one nucleic acid in library |
EP1275737B1 (en) * | 2001-06-30 | 2013-09-04 | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. | Process for mRNA detection or quantification |
US9777312B2 (en) | 2001-06-30 | 2017-10-03 | Enzo Life Sciences, Inc. | Dual polarity analysis of nucleic acids |
US9428797B2 (en) | 2001-06-30 | 2016-08-30 | Enzo Life Sciences, Inc. | Nucleic acid detecting or quantifying processes |
US9528146B2 (en) | 2001-06-30 | 2016-12-27 | Enzo Life Sciences, Inc. | Processes for detecting or quantifying more than one nucleic acid in a library |
US9790621B2 (en) | 2001-06-30 | 2017-10-17 | Enzo Life Sciences, Inc. | Composition of matter comprising library of first nucleic acid analyte copies |
US9745619B2 (en) | 2001-06-30 | 2017-08-29 | Enzo Biochem, Inc. | Process for detecting or quantifying nucleic acids in a library |
WO2003006657A2 (en) * | 2001-07-13 | 2003-01-23 | Custos Biotechnologie Gmbh | Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours |
WO2003006657A3 (en) * | 2001-07-13 | 2003-11-13 | Custos Biotechnologie Gmbh | Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours |
WO2003062462A3 (en) * | 2002-01-16 | 2003-12-11 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
US8110351B2 (en) * | 2002-01-16 | 2012-02-07 | Invitrogen Dynal As | Method for isolating nucleic acids and protein from a single sample |
WO2003062462A2 (en) * | 2002-01-16 | 2003-07-31 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
US20120178090A1 (en) * | 2002-01-16 | 2012-07-12 | Invitrogen Dynal As | Method for isolating nucleic acids and protein from a single sample |
US9068948B2 (en) | 2002-03-12 | 2015-06-30 | Enzo Life Sciences, Inc. | Processes for detection of nucleic acids |
US8158387B2 (en) | 2004-06-17 | 2012-04-17 | Korea Advanced Institute Of Science And Technology | Method for cell surface display of target proteins using FadL of E. coli |
DE112006003608T5 (en) | 2006-01-02 | 2008-10-30 | Korea Advanced Institute Of Science And Technology | A method of presenting target proteins at the cell surface using Bacillus Anthracis Exosporium |
US8883692B2 (en) | 2006-01-02 | 2014-11-11 | Korea Advanced Institute Of Science And Technology | Method for cell surface displaying of target proteins using Bacillus anthracis exosporium |
WO2010107825A2 (en) | 2009-03-16 | 2010-09-23 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
EP3255146A1 (en) | 2009-03-16 | 2017-12-13 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
WO2010120509A2 (en) | 2009-03-31 | 2010-10-21 | Atyr Pharma, Inc. | Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
WO2011139714A2 (en) | 2010-04-26 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
WO2011139799A2 (en) | 2010-04-27 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
WO2011139853A2 (en) | 2010-04-28 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
WO2011135459A2 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
WO2011139907A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
WO2011139854A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
WO2011140132A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
WO2011139986A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
WO2011140135A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
WO2011140267A2 (en) | 2010-05-04 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
WO2011143482A2 (en) | 2010-05-14 | 2011-11-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
WO2011146410A2 (en) | 2010-05-17 | 2011-11-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
WO2011150279A2 (en) | 2010-05-27 | 2011-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
WO2011153277A2 (en) | 2010-06-01 | 2011-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
WO2012021247A2 (en) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
WO2012027611A2 (en) | 2010-08-25 | 2012-03-01 | Atyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
WO2012163541A1 (en) | 2011-06-01 | 2012-12-06 | Medical Prognosis Institute A/S | Methods and devices for prognosis of cancer relapse |
WO2013123432A2 (en) | 2012-02-16 | 2013-08-22 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
EP3311847A1 (en) | 2012-02-16 | 2018-04-25 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
WO2014085434A1 (en) | 2012-11-27 | 2014-06-05 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
WO2014195032A1 (en) | 2013-06-07 | 2014-12-11 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
WO2016008048A1 (en) | 2014-07-15 | 2016-01-21 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
Also Published As
Publication number | Publication date |
---|---|
WO2000061806A3 (en) | 2001-12-20 |
AU4058100A (en) | 2000-11-14 |
EP1183387A2 (en) | 2002-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000061806A2 (en) | GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS | |
US20240003892A1 (en) | Heterogeneous single cell profiling using molecular barcoding | |
Venkatasubbarao | Microarrays–status and prospects | |
US8354231B2 (en) | Methods and systems for detecting and/or sorting targets | |
US8394590B2 (en) | Capture agents and related methods and systems for detecting and/or sorting targets | |
EP0139489A2 (en) | Sandwich hybridization method for nucleic acid detection | |
WO2009126828A2 (en) | Capture agents and related methods and systems for detecting and/or sorting targets | |
CN104745586B (en) | Cocaine aptamer, detection kit and application thereof | |
JP4425640B2 (en) | DNA-binding protein detection method | |
JP2002524739A (en) | Multi-colored signs | |
US6541203B2 (en) | Detecting structural or synthetic information about chemical compounds | |
JP2006523462A (en) | Oligonucleotide pairs for multiplex binding assays | |
CN105624164B (en) | Ketamine aptamer, detection kit and application thereof | |
US7611871B2 (en) | Method for the specific determination of DNA sequences by means of parallel amplification | |
JP2006518183A (en) | Encoding nucleic acid carrier | |
US20030073091A1 (en) | Use of generic oligonucleotide microchips to detect protein-nucleic acid interactions | |
JP2003527605A (en) | Methods for making and using biological material microarrays | |
WO2020033779A1 (en) | Exosome detection in microfluidic droplets | |
JP6076500B2 (en) | Target substance detection method | |
US5910410A (en) | Dual tag binding assay | |
US20050239078A1 (en) | Sequence tag microarray and method for detection of multiple proteins through DNA methods | |
CN116875673A (en) | System for diagnosing myocardial infarction | |
JP2003177131A (en) | Method for detecting biological bonding affinity | |
He | Development of on-chip proximity ligation assay with in situ single molecule sequencing readout | |
CA2408734A1 (en) | Compositions and methods for genetic analyses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000919976 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 2000919976 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000919976 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |